Sichuan Cancer Hosiptal
Sichuan Cancer Hosiptal
Chengdu, Sichuan, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Phase 2 | 2022-10-27 | NCT05595590 |